Zentalis Pharmaceuticals, Inc.

Biotechnology • Healthcare • San Diego, CA, United States • ZNTL (NGM)

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL) - Seeking Alpha

Seeking Alpha • Nov 18

We're Keeping An Eye On Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Rate - Yahoo Finance

Yahoo Finance • Dec 3

Zentalis Pharmaceuticals Announces Stock Repurchase Agreement - TipRanks

TipRanks • Dec 15

Insider Selling: Zentalis Pharmaceuticals (NASDAQ:ZNTL) Major Shareholder Sells 7,500,000 Shares of Stock - MarketBeat

MarketBeat • Dec 15

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire • Sep 2

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Zentalis Pharmaceuticals, Inc. had layoffs?

No layoff events have been recorded for Zentalis Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Zentalis Pharmaceuticals, Inc. have?

Zentalis Pharmaceuticals, Inc. has approximately 166 employees.

What industry is Zentalis Pharmaceuticals, Inc. in?

Zentalis Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Zentalis Pharmaceuticals, Inc. a publicly traded company?

Yes, Zentalis Pharmaceuticals, Inc. is publicly traded under the ticker symbol ZNTL on the NGM. The company has a market capitalization of approximately $0.10 billion.

Where is Zentalis Pharmaceuticals, Inc. headquartered?

Zentalis Pharmaceuticals, Inc. is headquartered in San Diego, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.